BI 1823911 clinical trials

A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

This study is for adults with advanced cancer that has a specific KRAS gene change. It tests new medicines, BI 1823911 alone and with BI 1701963, to see if they can shrink tumours. Currently, there are no other successful treatments.